These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8780156)
1. Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice. Perez-Stable C; Altman NH; Brown J; Harbison M; Cray C; Roos BA Lab Invest; 1996 Feb; 74(2):363-73. PubMed ID: 8780156 [TBL] [Abstract][Full Text] [Related]
2. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089. Perez-Stable CM; Schwartz GG; Farinas A; Finegold M; Binderup L; Howard GA; Roos BA Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):555-63. PubMed ID: 12050097 [TBL] [Abstract][Full Text] [Related]
3. Prostate cancer progression, metastasis, and gene expression in transgenic mice. Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192 [TBL] [Abstract][Full Text] [Related]
4. Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice. Reiner T; de Las Pozas A; Parrondo R; Perez-Stable C Mol Cancer Res; 2007 Nov; 5(11):1171-9. PubMed ID: 17982114 [TBL] [Abstract][Full Text] [Related]
5. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793 [TBL] [Abstract][Full Text] [Related]
6. Hecate-CGbeta conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-alpha promoter. Vuorenoja S; Mohanty BP; Arola J; Huhtaniemi I; Toppari J; Rahman NA Endocr Relat Cancer; 2009 Jun; 16(2):549-64. PubMed ID: 19261682 [TBL] [Abstract][Full Text] [Related]
7. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model. Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611 [TBL] [Abstract][Full Text] [Related]
8. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61. Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170 [TBL] [Abstract][Full Text] [Related]
9. Human prostate cancer progression models and therapeutic intervention. Chung LW; Kao C; Sikes RA; Zhau HE Hinyokika Kiyo; 1997 Nov; 43(11):815-20. PubMed ID: 9436028 [TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Latham JP; Searle PF; Mautner V; James ND Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585 [TBL] [Abstract][Full Text] [Related]
11. Human fetal-to-adult globin gene switching in transgenic mice: persistent expression of the G gamma-globin gene in the Japanese HPFH. Katsube T; Tojo H; Sakaguchi T; Fukumaki Y Biochem Biophys Res Commun; 1993 Jul; 194(1):246-52. PubMed ID: 7687430 [TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600 [TBL] [Abstract][Full Text] [Related]
13. Transgenic mouse models for prostate cancer. Identification of an androgen-dependent promoter and creation and characterization of the long probasin promoter-Large T antigen (LPB-Tag) model. Kasper S; Tu W; Roberts RL; Shappell SB Methods Mol Med; 2003; 81():113-47. PubMed ID: 12725118 [No Abstract] [Full Text] [Related]
14. A region upstream of the human delta-globin gene shows a stage-specific interaction with globin promoters in erythroid cell lines. Vitale M; Calzolari R; Di Marzo R; Acuto S; Maggio A Blood Cells Mol Dis; 2001; 27(5):874-81. PubMed ID: 11783950 [TBL] [Abstract][Full Text] [Related]
15. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer. Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652 [TBL] [Abstract][Full Text] [Related]
16. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Foster BA; Gingrich JR; Kwon ED; Madias C; Greenberg NM Cancer Res; 1997 Aug; 57(16):3325-30. PubMed ID: 9269988 [TBL] [Abstract][Full Text] [Related]
17. Expression and role of Foxa proteins in prostate cancer. Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449 [TBL] [Abstract][Full Text] [Related]
18. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer. Gotoh A; Ko SC; Shirakawa T; Cheon J; Kao C; Miyamoto T; Gardner TA; Ho LJ; Cleutjens CB; Trapman J; Graham FL; Chung LW J Urol; 1998 Jul; 160(1):220-9. PubMed ID: 9628654 [TBL] [Abstract][Full Text] [Related]
19. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model. Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752 [TBL] [Abstract][Full Text] [Related]
20. Compounds of the anthracycline family of antibiotics elevate human gamma-globin expression both in erythroid cultures and in a transgenic mouse model. Spyrou P; Phylactides M; Lederer CW; Kithreotis L; Kirri A; Christou S; Kkolou E; Kanavakis E; Anagnou NP; Stamatoyannopoulos G; Kleanthous M Blood Cells Mol Dis; 2010; 44(2):100-6. PubMed ID: 19914848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]